Skip to main content

Table 6 Cost-effectiveness of FSL compared with SMBG in T1DM and T2DM

From: Cost-effectiveness of continuous glucose monitoring with FreeStyle Libre® in Brazilian insulin-treated patients with types 1 and 2 diabetes mellitus

Alternative

Total cost

Total QALYs

Cost difference

QALY difference

ICER

NMB

T1DM

 FSL

R$ 8116

0.464

R$ 7255

0.276

R$ 26,268

R$ 3793

 SMBG

R$ 861

0.187

T2DM

 FSL

R$ 8116

0.607

R$ 7290

0.184

R$ 39,693

R$ 56

 SMBG

R$ 726

0.423

  1. T1DM, Type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; FSL, FreeStyle Libre; SMBG, self-monitoring of blood glucose; ICER, Incremental cost-effectiveness threshold ratio; NMB, Net Monetary Benefit